InsiderSignalSign in
← Insider buys

Noubar Afeyan has bought stock on 2 days since Jun 2019

Director at Moderna, Inc., and 2 other companies

SEC CIK 0001222012 · Filings on SEC.gov ↗

$95.0MBought
$1.7BSold
Mar 2Last buy

Noubar Afeyan's record

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Companies

Every filing

89 filings since May 2016, newest first

MRNASell

Moderna, Inc.

Director

$2.0MJan 20
MRNASell

Moderna, Inc.

Director

$1.9MJan 13
MRNASell

Moderna, Inc.

Director

$1.8MJan 6
MRNASell

Moderna, Inc.

Director

$2.0MDec 23
MRNASell

Moderna, Inc.

Director

$1.9MDec 16
MRNASell

Moderna, Inc.

Director

$1.7MDec 9
MRNASell

Moderna, Inc.

Director

$1.7MDec 2
MRNASell

Moderna, Inc.

Director

$1.8MNov 25
MRNASell

Moderna, Inc.

Director

$1.8MNov 18
MRNASell

Moderna, Inc.

Director

$1.6MNov 10
MRNASell

Moderna, Inc.

Director

$1.5MNov 4
MRNASell

Moderna, Inc.

Director

$1.4MOct 28
MRNASell

Moderna, Inc.

Director

$1.3MOct 21
MRNASell

Moderna, Inc.

Director

$1.4MOct 14
MRNASell

Moderna, Inc.

Director

$1.2MOct 7
MRNASell

Moderna, Inc.

Director

$1.2MSep 30
MRNASell

Moderna, Inc.

Director

$1.3MSep 23
MRNASell

Moderna, Inc.

Director

$1.3MSep 16
MRNASell

Moderna, Inc.

Director

$1.3MSep 9
MRNASell

Moderna, Inc.

Director

$1.4MSep 2
MRNASell

Moderna, Inc.

Director

$1.7MAug 19
MRNASell

Moderna, Inc.

Director

$1.7MAug 12
MRNASell

Moderna, Inc.

Director

$1.7MAug 5
MRNASell

Moderna, Inc.

Director

$1.6MJul 29
MRNASell

Moderna, Inc.

Director

$1.7MJul 22
MRNASell

Moderna, Inc.

Director

$1.7MJul 15
MRNASell

Moderna, Inc.

Director

$1.5MJul 8
MRNASell

Moderna, Inc.

Director

$1.4MJul 1
MRNASell

Moderna, Inc.

Director

$1.3MJun 24
MRNASell

Moderna, Inc.

Director

$1.5MJun 10
MRNASell

Moderna, Inc.

Director

$1.5MJun 3
MRNASell

Moderna, Inc.

Director

$1.3MMay 27
MRNASell

Moderna, Inc.

Director

$1.4MMay 20
MRNASell

Moderna, Inc.

Director

$40.9M−2.0%May 13
MRNASell

Moderna, Inc.

Director

$455.7M−14.0%Mar 31
MRNASell

Moderna, Inc.

Director

$730.1M−15.0%Feb 24
MRNASell

Moderna, Inc.

Director

$256.4M−6.0%Feb 24
MCRBBuy

Seres Therapeutics, Inc.

Director and 10% owner

$20.0M+108.0%Jun 20
MCRBSell

Seres Therapeutics, Inc.

Director and 10% owner

$27.6M−100.0%May 27
Newer filings
About Noubar Afeyan

Noubar Afeyan is a prominent entrepreneur and venture capitalist who serves as Co-Founder and Chairman of Generate:Biomedicines, as well as Founder and CEO of Flagship Pioneering, a leading life sciences venture capital firm( With a Ph.D. in chemical engineering, Afeyan has built a distinguished career at the intersection of science and entrepreneurship, founding and leading multiple biotech ventures. He holds approximately 57.7% ownership in Generate:Biomedicines, the Somerville, Massachusetts-based company that uses artificial intelligence to revolutionize drug discovery and create new protein-based therapeutics(

As a director and 10% public owner of Generate:Biomedicines, Afeyan has been actively engaged in the company's recent capital activities( In February 2026, Afeyan received a stock option covering 29,561 shares vesting in February 2027, and Flagship Pioneering-affiliated funds under his direction purchased 4.6 million shares of common stock at $16.00 per share( His leadership extends beyond Generate:Biomedicines through Flagship Pioneering, where he directs a portfolio of innovative life sciences companies and maintains significant influence over the firm's strategic investments and operations.

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.